1390 related articles for article (PubMed ID: 21701385)
1. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB
Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385
[TBL] [Abstract][Full Text] [Related]
2. Serum B-type natriuretic peptide levels on admission predict not only short-term death but also angiographic success of procedure in patients with acute ST-elevation myocardial infarction treated with primary angioplasty.
Grabowski M; Filipiak KJ; Karpinski G; Wretowski D; Rdzanek A; Huczek Z; Horszczaruk GJ; Kochman J; Rudowski R; Opolski G
Am Heart J; 2004 Oct; 148(4):655-62. PubMed ID: 15459597
[TBL] [Abstract][Full Text] [Related]
3. Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction.
Jeong YH; Kim WJ; Park DW; Choi BR; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ
Int J Cardiol; 2010 May; 141(2):175-81. PubMed ID: 19144424
[TBL] [Abstract][Full Text] [Related]
4. B-type natriuretic peptide predicts new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
Asanin M; Stankovic S; Mrdovic I; Matic D; Savic L; Majkic-Singh N; Ostojic M; Vasiljevic Z
Peptides; 2012 May; 35(1):74-7. PubMed ID: 22421508
[TBL] [Abstract][Full Text] [Related]
5. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
[TBL] [Abstract][Full Text] [Related]
7. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty.
Grabowski M; Filipiak KJ; Malek LA; Karpinski G; Huczek Z; Stolarz P; Spiewak M; Kochman J; Rudowski R; Opolski G
Int J Cardiol; 2007 Feb; 115(3):386-90. PubMed ID: 16860415
[TBL] [Abstract][Full Text] [Related]
8. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
[TBL] [Abstract][Full Text] [Related]
9. Impact of admission glomerular filtration rate on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction.
Celik T; Iyisoy A; Yuksel CU; Kilic S; Yilmaz MI; Akgul EO; Jata B; Isik E
Coron Artery Dis; 2008 Dec; 19(8):543-9. PubMed ID: 19005288
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention.
Verouden NJ; Haeck JD; Kuijt WJ; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; van Straalen JP; Fischer J; Piek JJ; Tijssen JG; de Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1047-52. PubMed ID: 20381651
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of the admission plasma B-type natriuretic peptide measurement in patients with first ST-elevation myocardial infarction in comparison with C-reactive protein and TIMI risk score.
Kuklinska AM; Sobkowicz B; Mroczko B; Sawicki R; Musial WJ; Knapp M; Dobrzycki S; Szmitkowski M
Clin Chim Acta; 2007 Jul; 382(1-2):106-11. PubMed ID: 17482153
[TBL] [Abstract][Full Text] [Related]
12. Multiple biomarkers at admission are associated with angiographic, electrocardiographic, and imaging cardiovascular mechanistic markers of outcomes in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.
Damman P; Kuijt WJ; Woudstra P; Haeck JD; Koch KT; Gu YL; van Straalen JP; Fischer J; Tijssen JG; Krucoff MW; de Winter RJ
Am Heart J; 2012 May; 163(5):783-9. PubMed ID: 22607855
[TBL] [Abstract][Full Text] [Related]
13. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
Kwon TG; Bae JH; Jeong MH; Kim YJ; Hur SH; Seong IW; Cho MC; Seung KB; Jang YS; Park SJ;
Int J Cardiol; 2009 Apr; 133(2):173-8. PubMed ID: 18281115
[TBL] [Abstract][Full Text] [Related]
14. In-hospital prognostic value of admission plasma B-type natriuretic peptide levels in patients undergoing primary angioplasty for acute ST-elevation myocardial infarction.
Oduncu V; Erkol A; Tanalp AC; Dündar C; Tanboğa IH; Sırma D; Karagöz A; Karabay CY; Izgi A; Pala S; Tigen K; Kırma C
Turk Kardiyol Dern Ars; 2011 Oct; 39(7):540-8. PubMed ID: 21983763
[TBL] [Abstract][Full Text] [Related]
15. Elevated admission serum creatinine predicts poor myocardial blood flow and one-year mortality in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
Zhao L; Wang L; Zhang Y
J Invasive Cardiol; 2009 Oct; 21(10):493-8. PubMed ID: 19805833
[TBL] [Abstract][Full Text] [Related]
16. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
Akpek M; Kaya MG; Lam YY; Sahin O; Elcik D; Celik T; Ergin A; Gibson CM
Am J Cardiol; 2012 Sep; 110(5):621-7. PubMed ID: 22608360
[TBL] [Abstract][Full Text] [Related]
17. The usefulness of myeloperoxidase in prediction of in-hospital mortality in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
Stankovic S; Asanin M; Majkic-Singh N; Ignjatovic S; Mihailovic M; Nikolajevic I; Mrdovic I; Matic D; Savic L; Marinkovic J; Ostojic M; Vasiljevic Z
Clin Lab; 2012; 58(1-2):125-31. PubMed ID: 22372355
[TBL] [Abstract][Full Text] [Related]
18. Predictors and outcome of grade 3 ischemia in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Postma S; Heestermans T; Ten Berg JW; van Werkum JW; Suryapranata H; Birnbaum Y; Hamm CW; van 't Hof AW
J Electrocardiol; 2011; 44(5):516-22. PubMed ID: 21871998
[TBL] [Abstract][Full Text] [Related]
19. Relationship between TIMI frame count and admission glucose values in acute ST elevation myocardial infarction patients who underwent successful primary percutaneous intervention.
Ege M; Güray U; Güray Y; Yılmaz MB; Demirkan B; Saşmaz A; Korkmaz S
Anadolu Kardiyol Derg; 2011 May; 11(3):213-7. PubMed ID: 21421510
[TBL] [Abstract][Full Text] [Related]
20. Changes in BNP, hs-CRP and TIMI risk index with addition of tirofiban during primary percutaneous coronary intervention for acute STEMI: a prospective observational cohort study.
Kurt IH; Demirkol S; Ünal I; Batur MK
Anadolu Kardiyol Derg; 2012 Mar; 12(2):107-14. PubMed ID: 22281789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
